Sildenafil Tablet
Product Images NDC 50268-717

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50268-717). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 5026871715 Sildenafil 2015 20mg

Sildenafil Tablets 20 mg oral tablets carton label by AvPAK, NDC 50268-717-15. The label indicates the package contains 50 tablets (5 strips of 10 unit doses) for prescription use only. Storage instructions and pharmacist dispensing directions are also included on the label.*

FDA Label Image

F7c6df1a-figure-01 (Sildenafil Tablets 1)

A step plot graph showing estimated cumulative mortality rates over time (in years) for three dosage groups labeled High Dose, Medium Dose, and Low Dose. The vertical axis represents mortality rate percentage, and the horizontal axis represents time up to five years. A table at the top displays the number of subjects at risk for each dose group at various time points.*

FDA Label Image

F7c6df1a-figure-02 (Sildenafil Tablets 2)

Chemical structure of Sildenafil, showing its molecular components and arrangement including sulfonamide, piperazine, and purine analog elements.*

FDA Label Image

F7c6df1a-figure-03 (Sildenafil Tablets 3)

A horizontal dot plot chart showing the fold change and 90% confidence interval for various interacting drugs relative to Sildenafil alone based on AUC and Cmax values. The chart includes drugs like Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir, along with dosing recommendations such as no dose adjustment or avoidance of coadministration.*

FDA Label Image

F7c6df1a-figure-04 (Sildenafil Tablets 4)

A chart depicting the fold change and 90% confidence interval of various interacting drugs relative to interacting drug alone on the X-axis, with a vertical solid line at 1. The chart shows data for drugs including Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide, along with dose adjustment recommendations.*

FDA Label Image

F7c6df1a-figure-05 (Sildenafil Tablets 5)

A line graph showing changes from baseline measured in centimeters at Weeks 4, 6, and 12. The graph compares four groups: Sildenafil 40 mg TID, Placebo, Sildenafil 60 mg TID, and Sildenafil 20 mg TID, each represented by different symbols and lines with error bars.*

FDA Label Image

F7c6df1a-figure-06 (Sildenafil Tablets 6)

A horizontal forest plot chart showing placebo-corrected changes in 6-minute walk distance (meters) for Sildenafil 20 mg taken three times daily. The chart compares subgroups by baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean pulmonary arterial pressure, and pulmonary vascular resistance index, with data points representing effect size and horizontal lines showing confidence intervals.*

FDA Label Image

F7c6df1a-figure-07 (Sildenafil Tablets 7)

A Kaplan-Meier survival curve comparing the percentage of subjects without a clinically worsening event over days from randomization between sildenafil and placebo groups. The y-axis shows the percentage without event, and the x-axis represents days from randomization, with sildenafil showing a higher survival without worsening compared to placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.